SC
BIVI icon

Shay Capital’s BioVie BIVI Stock Holding History

Shay Capital’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-236
Closed -$106K – 515
2021
Q4 		$106K Buy
236
+7
+3% +$4.04K 0.02% 394
2021
Q3 		$153K Buy
+229
New +$245K 0.02% 420
2021
Q2 		– Sell
-204
Closed -$394K – 530
2021
Q1 		$394K Sell
204
-37
-15% -$106K 0.04% 272
2020
Q4 		$418K Buy
+241
New +$241K 0.09% 174

Other funds holding BIVI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Shay Capital's BIVI Position: Q1 2022 in Review

Shay Capital sold out of BioVie (BIVI) in Q1 2022, closing a stake of 236 shares — an estimated $106K sold.

Shay Capital first reported a position in BIVI in Q4 2020 and held it in 4 quarters. The position peaked at $418K in Q4 2020. 14 funds tracked by Wall St. Rank hold BIVI as of Q1 2022.

  • Shay Capital reported no remaining BioVie position as of Q1 2022 after selling out during the quarter.
  • Shay Capital sold 236 BioVie shares in Q1 2022, an estimated $106K.
  • Shay Capital first reported a position in BioVie in Q4 2020 and held it in 4 quarters.
  • Shay Capital's BioVie position peaked at $418K in Q4 2020.
  • 14 funds tracked by Wall St. Rank held BioVie as of Q1 2022.

Based on Shay Capital's 13F filing for Q1 2022, filed 16 May 2022.